These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 27410690)
1. Novel Treatment Using Cimetidine for Erythropoietic Protoporphyria in Children. Tu JH; Sheu SL; Teng JM JAMA Dermatol; 2016 Nov; 152(11):1258-1261. PubMed ID: 27410690 [TBL] [Abstract][Full Text] [Related]
2. Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria. Yasuda M; Lee S; Gan L; Bergonia HA; Desnick RJ; Phillips JD Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254627 [TBL] [Abstract][Full Text] [Related]
9. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report. Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647 [TBL] [Abstract][Full Text] [Related]
10. Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review. Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC Biomed Pharmacother; 2023 Feb; 158():114132. PubMed ID: 36525819 [TBL] [Abstract][Full Text] [Related]
11. Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria. Biolcati G; Marchesini E; Sorge F; Barbieri L; Schneider-Yin X; Minder EI Br J Dermatol; 2015 Jun; 172(6):1601-1612. PubMed ID: 25494545 [TBL] [Abstract][Full Text] [Related]
12. Variable effects of beta-carotene therapy in a child with erythropoietic protoporphyria. Alemzadeh R; Feehan T Eur J Pediatr; 2004 Sep; 163(9):547-9. PubMed ID: 15241683 [TBL] [Abstract][Full Text] [Related]
13. Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Wensink D; Wagenmakers MAEM; Langendonk JG Expert Rev Clin Pharmacol; 2021 Feb; 14(2):151-160. PubMed ID: 33507118 [No Abstract] [Full Text] [Related]
14. Acquired erythropoietic protoporphyria: A systematic review of the literature. Snast I; Kaftory R; Sherman S; Edel Y; Hodak E; Levi A; Lapidoth M Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):29-33. PubMed ID: 31374130 [TBL] [Abstract][Full Text] [Related]
15. [Anesthetic management of a patient with erythropoietic protoporphyria for laparoscopic appendectomy]. Kuwahara Y; Taguchi S; Fukuda H; Hamada H; Kawamoto M Masui; 2011 Apr; 60(4):470-2. PubMed ID: 21520598 [TBL] [Abstract][Full Text] [Related]
16. Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice. Wensink D; Wagenmakers MAEM; Barman-Aksözen J; Friesema ECH; Wilson JHP; van Rosmalen J; Langendonk JG JAMA Dermatol; 2020 May; 156(5):570-575. PubMed ID: 32186677 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284 [TBL] [Abstract][Full Text] [Related]
18. Effects of iron supplements in individuals with erythropoietic protoporphyria. Heerfordt IM; Lerche CM; Philipsen PA; Wulf HC Photodiagnosis Photodyn Ther; 2024 Jun; 47():104211. PubMed ID: 38734198 [TBL] [Abstract][Full Text] [Related]
19. Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study. Minder AE; Barman-Aksoezen J; Schmid M; Minder EI; Zulewski H; Minder CE; Schneider-Yin X Ther Adv Rare Dis; 2021; 2():26330040211065453. PubMed ID: 37181106 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietic protoporphyria and early onset of cholestasis. Khalili MJ; Farahmand F; Hirbod-Mobarakeh A; Yousefi A; Sotoudeh S; Monajemzadeh M; Razaghian A; Rezaei N Turk J Pediatr; 2012; 54(6):645-50. PubMed ID: 23692792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]